CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 71 enrolled
Drug / intervention
Acetaminophen +1 moredrug
Likely dose
Acetaminophen 15 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03541980
NCT03541980Phase 4Completed
CompareCT.gov

Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?

Newark Beth Israel Medical Center·interventional·Posted May 31, 2018·Updated Apr 2, 2021

In Brief

A Phase 4 clinical trial evaluating Acetaminophen and Normal saline for Sickle Cell Anemia Crisis. Completed, enrolled 71 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether IV acetaminophen can decrease the need for subsequent opioid administration in the acute management of sickle cell crisis pain in the pediatric emergency room.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Anemia Crisis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMay 31, 2018
Enrollment StartFeb 20, 2018
Primary CompletionFeb 20, 2020
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 8.1 years ago

Interventions

Acetaminophendrug

Administration of 15 mg/kg (1000 mg max dose) of IV acetaminophen

Normal salinedrug

Normal saline volume equivalent